The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

Proposal would let patients get Wegovy, Ozempic, related drugs for obesity, which is not a covered condition now.

A row is brewing between the White House and Robert F Kennedy Jr after the Biden administration proposed making millions of ...

This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.

The proposal, which would not be finalized until after President-elect Donald Trump takes office, could cost taxpayers as ...

The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for patients ...

Medicare and Medicaid would be required to cover weight loss drug prescriptions for millions of obese Americans under plans ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...